Patient Capital Management’s Brilliant Earth BRLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,000
Closed -$158K 41
2025
Q1
$158K Hold
100,000
0.01% 39
2024
Q4
$210K Sell
100,000
-141,445
-59% -$260K 0.01% 43
2024
Q3
$517K Hold
241,445
0.03% 41
2024
Q2
$536K Sell
241,445
-8,555
-3% -$21.6K 0.03% 39
2024
Q1
$748K Hold
250,000
0.04% 41
2023
Q4
$930K Hold
250,000
0.05% 43
2023
Q3
$738K Buy
250,000
+198,632
+387% +$713K 0.04% 42
2023
Q2
$199K Buy
+51,368
New +$195K 0.01% 44
2022
Q4
Sell
-75,000
Closed -$430K 45
2022
Q3
$430K Buy
+75,000
New +$484K 0.21% 42

Other funds holding BRLT

Patient Capital Management's BRLT Position: Q2 2025 in Review

Patient Capital Management sold out of Brilliant Earth (BRLT) in Q2 2025, closing a stake of 100,000 shares — an estimated $158K sold.

Patient Capital Management first reported a position in BRLT in Q3 2022 and held it in 9 quarters. The position peaked at $930K in Q4 2023. 37 funds tracked by Wall St. Rank hold BRLT as of Q2 2025.

  • Patient Capital Management reported no remaining Brilliant Earth position as of Q2 2025 after selling out during the quarter.
  • Patient Capital Management sold 100,000 Brilliant Earth shares in Q2 2025, an estimated $158K.
  • Patient Capital Management first reported a position in Brilliant Earth in Q3 2022 and held it in 9 quarters.
  • Patient Capital Management's Brilliant Earth position peaked at $930K in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Brilliant Earth as of Q2 2025.

Based on Patient Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.